UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.
A $10 million grant over four years will support further examination of a national study looking at COVID-19 vaccination safety during pregnancy and immune response pre-and post-delivery for both mom and baby.
COVID-19 rebound following Paxlovid treatment likely due to insufficient drug exposure, UC San Diego researchers find after showing rebound patient did not show drug resistance or impaired immunity.
UC San Diego researchers report significant decrease in national cases of Kawasaki disease during COVID-19 pandemic; findings hint at origins of disease.
A UC San Diego clinical trial finds new Guided Self-Help program is effective in treating pediatric obesity and improving family attendance rates.
A UC San Diego study describes the short- and long-term neurological symptoms of SARS-CoV-2 infection, and identifies a new group of COVID-19 long-haulers with advanced motor and cognitive symptoms.
UC San Diego researchers describe connection between pediatric liver disease and increased risk of developing type 2 diabetes. Both rates are rising in children.
SELF Magazine, May 12
Forbes, May 29
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
